JOSE ANTONIO
IRIBARREN LOYARTE
PROFESORADO AGREGADO
![Foto de JOSE ANTONIO](/img/nophoto.png)
![Foto de Hospital General Universitario Reina Sofía](/img/noimage_org.png)
Hospital General Universitario Reina Sofía
Murcia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital General Universitario Reina Sofía (11)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
2023
-
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
EBioMedicine, Vol. 95, pp. 104773
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
2020
-
Deprescribing of non-antiretroviral therapy in HIV-infected patients
European Journal of Clinical Pharmacology, Vol. 76, Núm. 3, pp. 305-318
2019
-
CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients
Cellular and Molecular Immunology, Vol. 16, Núm. 12, pp. 940-942
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
-
Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy
Journal of Translational Medicine, Vol. 16, Núm. 1
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
2015
-
Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort
Antiviral Research, Vol. 117, pp. 69-74